Results also show that reducing the Padcev dose at treatment initiation may benefit older patients with urothelial carcinoma, ...
Vimseltinib is now an FDA-approved treatment for patients with tenosynovial giant cell tumor, based on findings from the ...
An unusual swelling in the legs and feet could indicate the onset of kidney damage. When the kidneys struggle to eliminate ...
Using turmeric every day can transform your skin scalp, and hair. Here’s how this natural remedy helps give you glowing skin ...
Frequency of Eye Diseases in Subjects Aged 40 and Over. Open Journal of Ophthalmology, 15, 11-17. doi: ...
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) announced that the U.S. Food and Drug Administration (FDA) has approved ROMVIMZA™ (vimseltinib), a kinase ...
Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic dermatitis and prurigo nodularis in the European Union (EU). Nemluvio is now ...
Findings also suggested that an up-front dose reduction of enfortumab vedotin may benefit older patients with urothelial carcinoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback